Sentry LLC’s Bristol-Myers Squibb BMY Stock Holding History

Sentry LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	17,172 -896	-5%	-$52.2K	0.33%	42
2025 Q4	$975K	Hold	18,068	–	–	0.27%	45
2025 Q3	$815K	Hold	18,068	–	–	0.2%	50
2025 Q2	$836K	Hold	18,068	–	–	0.17%	51
2025 Q1	$1.1M	Buy	18,068 +901	+5%	+$52.5K	0.21%	38
2024 Q4	$971K	Sell	17,167 -901	-5%	-$50.3K	0.19%	42
2024 Q3	$935K	Buy	18,068 +37	+0.2%	+$1.74K	0.18%	43
2024 Q2	$749K	Sell	18,031 -101	-0.6%	-$4.52K	0.14%	51
2024 Q1	$983K	Sell	18,132 -183	-1%	-$9.32K	0.19%	43
2023 Q4	$940K	Hold	18,315	–	–	0.2%	40
2023 Q3	$1.06M	Hold	18,315	–	–	0.22%	35
2023 Q2	$1.17M	Hold	18,315	–	–	0.25%	33
2023 Q1	$1.27M	Buy	+18,315	New	+$1.29M	0.3%	29

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sentry LLC's BMY Position: Q1 2026 in Review

Sentry LLC reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, selling an estimated $52.2K and leaving 17,172 shares worth $1.04M. The position accounts for 0.33% of the portfolio, ranked #42.

Sentry LLC first reported a position in BMY in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.27M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Sentry LLC held 17,172 shares of Bristol-Myers Squibb worth $1.04M as of Q1 2026.
Sentry LLC sold 896 Bristol-Myers Squibb shares in Q1 2026, an estimated $52.2K.
Bristol-Myers Squibb made up 0.33% of Sentry LLC's portfolio in Q1 2026, its #42 holding.
Sentry LLC first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 13 quarters since.
Sentry LLC's Bristol-Myers Squibb position peaked at $1.27M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.